EPITA – The European Pancreas and Islet Transplant Association – announce a call for nominations for two new Board members.
Category: Kidney
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)
Abstract Non-invasive biomarkers are promising tools for improving kidney allograft rejection monitoring, but their clinical adoption requires more evidence in specifically designed studies. To address this unmet need, we designed the EU-TRAIN study, a large prospective multicentric unselected cohort funded by the European Commission. Here, we included consecutive adult patients who received a kidney allograft
New Course Available: Management of CMV in Solid Organ Transplant Patients on Transplant Live
This comprehensive course is composed of three modules that will be released regularly over the next few weeks. These resources are available for free on Transplant Live for all ESOT members.
Opportunity: Secure Your Seat as an Observer at the LIDO Masterclass 2024 in Rotterdam!
One exclusive observer seat is available for the LIDO Masterclass 2024 in Rotterdam this October! Secure your spot now !
Maximise Your Impact with ESOT!
Improving transplant patient outcomes is at the forefront of our mission and, we are eager to collaborate with research teams who share the common goal of improving the lives of those hindered by inequitable access to life-changing treatments and procedures. Here’s why our involvement can be a game-changer for your project: Unmatched Expertise: With a
New resource available on Transplant Live: Management of CMV in solid organ transplant recipients
We are pleased to announce that our latest workshop, titled “Managing CMV in Solid Organ Transplant Recipients” is now available on ESOT Transplant Live [when in Transplant Live please go to Courses]. This educational programme aims to enhance the management of Cytomegalovirus (CMV) infections among transplant recipients, which can pose a significant challenge post-surgery. The
Older live donors versus standard criteria donors kidneys
In the latest issue of Transplant International, Patel and colleagues are showing that patients receiving a kidney from older (>60 years) live donors have a survival advantage not only over patients remaining on dialysis but also over kidney recipients from standard criteria deceased donors.
ESOT Masterclass Now Accepting Applications!
Aimed at young professional working in solid organ transplant, this Masterclass will provide crucial insight into the cutting-edge technologies that are about to revolutionise the transplantation field, including cell-free DNA, new plasma, urinary and immune function biomarkers, gene-expression profiling, as well as recent advances on HLA and non-HLA antibodies.
ESOT manual for clinical practice guidelines
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
Progress in Communication and Dissemination at Recent HORUS General Assembly
ESOT Unveils Progress in Communication and Dissemination at Recent HORUS General Assembly